ÃֽŠÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
2¿ù ÀÇ°úÇÐ Å°¿öµå ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2¿ù¿¡ ÀÇ°úÇÐºÐ¾ß ±¹³»Àú³Î°ú ±¹Á¦ Àú³ÎÀ» ÅëÇØ ¹ßÇ¥ÇÑ ³í¹® ÃÑ 3,173ÆíÀ» ºÐ¾ßº°·Î ºÐ·ùÇÏ¿© Å°¿öµå ºÐ¼®ÇÏ¿´´Ù. 2¿ù¿¡ ¹ßÇ¥µÈ ÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ºÐ¼®¿¡¼ COVID-19, Vaccination, Complication, Risk, Neoplasm µîÀ» Áß½ÉÀ¸·Î ÇÏ´Â Å°¿öµå´Â Áö¼ÓÀûÀ¸·Î ÀÇ°úÇкоßÀÇ ÇÙ½É ÅäÇÈÀ¸·Î ³ªÅ¸³µÀ¸¸ç, ÁÖ¿ä ¿¬±¸µ¿Çâ ³×Æ®¿öÅ©¸¦ Çü¼ºÇÏ¿´´Ù. ƯÈ÷ COVID-19¿Í °ü·ÃµÈ °³³äÀÎ vaccination, complication, risk, mortality ¹× global Health µîÀÇ °³³äÀº ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£Çко߿¡¼ ÁÖ¿ä °ü½É ¿¬±¸ÁÖÁ¦·Î ³ªÅ¸³µ´Ù. ÀÇ°úÇבּ¸µ¿Ç⠺м®¿¡ »ç¿ëµÈ ³í¹®µ¥ÀÌÅÍ´Â 2022³â 2¿ù¿¡ ±¹³»¿Í ±¹¿Ü Àú³ÎÀ» ÅëÇØ ¹ßÇ¥µÈ ³í¹® Áß¿¡¼ Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¿Í Æà¸Þµå(PubMed) µ¥ÀÌÅͺ£À̽º¿¡ À妽ºµÈ ³í¹®ÀڷḦ ÃßÃâÇÏ¿© ºÐ¼®ÇÏ¿´´Ù.
ÀÇ°úÇÐ ºÐ¾ßº° ¹ßÇ¥ÇöȲÀ» »ìÆ캸¸é ÀÓ»óÀÇÇÐ 1,586Æí, ±âÃÊÀÇÇÐ 1,098Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 333Æí, °£È£ÇÐ 77Æí, Ä¡ÀÇÇÐ 79ÆíÀ¸·Î ³ªÅ¸³µ´Ù. ±¹³» Àú³ÎÀ» ÅëÇØ 755ÆíÀÌ °ÔÀçµÇ¾úÀ¸¸ç, ±¹¿Ü Àú³ÎÀ» ÅëÇÑ ³í¹®Àº 2,148ÆíÀ¸·Î ±¹Á¦Àú³ÎÀ» ÅëÇÑ ³í¹®¹ßÇ¥°¡ 27.2% ³ôÀº ºñÁßÀ» Â÷ÁöÇÏ¿´´Ù. ¿¬±¸¹ßÇ¥ ½ÇÀûÀ» Àü¿ù 1¿ù¿¡ ¹ßÇ¥µÈ 2,944Æí°ú ºñ±³Çϸé 229Æí °¨¼ÒÇÑ Ãß¼¼¸¦ ³ªÅ¸³»¾ú´Ù. ÀÇ°úÇÐ Àüü ±¹³»Àú³Î ¹× ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ Å°¿öµå¸¦ ÅëÇÕ ºÐ¼®ÇÑ ÈÄ¿¡ ºÐ¾ßº°·Î ±âÃÊÀÇÇÐ, ÀÓ»óÀÇÇÐ, ¿¹¹æÀÇÇÐ, Ä¡ÀÇÇÐ, °£È£ÇÐ ºÐ¾ß·Î ¼¼ºÎ ºÐ·ùÇÏ¿© ÃֽŠÇÙ½É ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© Ŭ¶ó¿ìµå ºÐ¼® ¹× ÇÙ½É Å°¿öµå¸¦ ºÐ¼® ÃßÃâÇÏ¿´´Ù. ºÐ¾ßº° ÇÙ½É ¿¬±¸µ¿Çâ Å°¿öµå Ŭ¶ó¿ìµå´Â ¾Æ·¡¿Í °°´Ù.
Ç¥ 1. 2¿ù ÀÇ°úÇÐ ÅëÇÕ ¿¬±¸µ¿Çâ »óÀ§ Å°¿öµå(N=3,173)
Å°¿öµå ¼øÀ§
|
±¹³» ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
±¹¿Ü ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
ÀÇ°úÇÐ ¿¬±¸µ¿Çâ
|
1
|
Risk
|
Risk
|
Risk
|
2
|
COVID-19
|
Genes
|
Genes
|
3
|
Vaccination
|
Neoplasms
|
Neoplasms
|
4
|
Women
|
Attention
|
Women
|
5
|
Stroke
|
Women
|
Attention
|
6
|
Complication
|
Humans
|
Role
|
7
|
Genes
|
Role
|
COVID-19
|
8
|
General Surgery
|
General Surgery
|
Humans
|
9
|
Role
|
Sensitivity And Specificity
|
General Surgery
|
10
|
Neoplasms
|
Survival Rate
|
Complication
|
±×¸² 1. ÀÇ°úÇÐ ÅëÇÕ 2¿ù ÇÙ½É Å°¿öµå ¿¬±¸µ¿Çâ Ŭ¶ó¿ìµå
±×¸² 2. ±¹³» Àú³Î ¹ßÇ¥ 2¿ù ÀÇ°úÇÐ ¿¬±¸µ¿Çâ Å°¿öµå ³×Æ®¿öÅ© ºÐ¼®
±×¸² 3. ±¹¿Ü Àú³Î ¹ßÇ¥ 2¿ù ÀÇ°úÇÐ ¿¬±¸µ¿Çâ ³×Æ®¿öÅ© ºÐ¼®
Ç¥ 2. ÀÇ°úÇÐ 2¿ù ÅäÇÈ ³×Æ®¿öÅ© ¸ðµ¨¸µ
Topic1
|
Topic2
|
Topic3
|
Topic4
|
Topic5
|
In Vitro Techniques
|
Complication
|
Neoplasms
|
Sensitivity & Specificity
|
Pediatrics
|
Metabolism
|
Mortality
|
Recurrence
|
Vaccination
|
Women
|
DNA
|
Risk
|
Liver
|
COVID-19
|
Exercise
|
Anti-Bacterial Agents
|
Death
|
Survival Rate
|
Water
|
Depression
|
Efficiency
|
Population
|
General Surgery
|
Soil
|
Pain
|
Genes
|
Women
|
Prognosis
|
Attention
|
Adult
|
Economics
|
Stroke
|
Drug
|
F-18 Fdg Pet
|
Older Adults
|
Attention
|
Adult
|
Neoplasm Metastasis
|
Environment
|
Behavior
|
Humans
|
Diabetes
|
Drug Therapy
|
Technology
|
Brain
|
Role
|
General Surgery
|
Fibrosis
|
Efficiency
|
Risk
|
±×¸² 4. ÀÇ°úÇÐ Å°¿öµå ÃßÃ⠸𵨸µ ³×Æ®¿öÅ© ºÐ¼®
ºÐ¾ßº° ÀÇ°úÇÐ ³í¹® ¹ßÇ¥ÇöȲÀº ÀÓ»óÀÇÇÐ 1,586Æí, ±âÃÊÀÇÇÐ 1,098Æí, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ 333Æí, Ä¡ÀÇÇÐ 79Æí, °£È£ÇÐ 77Æí ¼øÀ¸·Î ¹ßÇ¥µÇ¾î ÀÓ»óÀÇÇÐºÐ¾ß ³í¹®¹ßÇ¥°¡ ÀÇ°úÇко߿¡¼ 50%¸¦ Â÷ÁöÇÏ¿© °¡Àå ¸¹Àº ³í¹®½ÇÀûÀ» ³ªÅ¸³»¾ú´Ù. ±¹³»¹ßÇ¥¿Í ±¹¿Ü¹ßÇ¥¸¦ ºñ±³ÇØ º¼ ¶§ ±¹³» ³í¹®¹ßÇ¥´Â 755Æí ±¹¿Ü¹ßÇ¥´Â 2,418ÆíÀ¸·Î ±¹³»¹ßÇ¥´Â ÀüüÀÇ 31.2%¿¡ ºÒ°úÇÏ¿´´Ù. ÀÌ´Â ±¹³» ÀÇ°úÇÐºÐ¾ß ¿¬±¸ÀÚµéÀÌ ±¹¿Ü ÇмúÁö¸¦ ÅëÇØ ¿¬±¸½ÇÀû ¹ßÇ¥¸¦ ¼±È£ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø
* º» ³»¿ëÀº MedRIC (www.medric.or.kr)ÀÇ ¿¬±¸µ¿Çâ¿¡¼ ¼ºñ½ºµÇ´Â ³»¿ëÀÔ´Ï´Ù.